These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7723012)

  • 21. Evaluating protein structures determined by structural genomics consortia.
    Bhattacharya A; Tejero R; Montelione GT
    Proteins; 2007 Mar; 66(4):778-95. PubMed ID: 17186527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing atomistic simulation data with the NMR experiment: how much can NOEs actually tell us?
    Zagrovic B; van Gunsteren WF
    Proteins; 2006 Apr; 63(1):210-8. PubMed ID: 16425239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An empirical backbone-backbone hydrogen-bonding potential in proteins and its applications to NMR structure refinement and validation.
    Grishaev A; Bax A
    J Am Chem Soc; 2004 Jun; 126(23):7281-92. PubMed ID: 15186165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear magnetic resonance solution structure of the Arc repressor using relaxation matrix calculations.
    Bonvin AM; Vis H; Breg JN; Burgering MJ; Boelens R; Kaptein R
    J Mol Biol; 1994 Feb; 236(1):328-41. PubMed ID: 8107113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal protein L9: a structure determination by the combined use of X-ray crystallography and NMR spectroscopy.
    Hoffman DW; Cameron CS; Davies C; White SW; Ramakrishnan V
    J Mol Biol; 1996 Dec; 264(5):1058-71. PubMed ID: 9000630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure and dynamics of PEC-60, a protein of the Kazal type inhibitor family, determined by nuclear magnetic resonance spectroscopy.
    Liepinsh E; Berndt KD; Sillard R; Mutt V; Otting G
    J Mol Biol; 1994 May; 239(1):137-53. PubMed ID: 8196042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refinement of NMR structures using implicit solvent and advanced sampling techniques.
    Chen J; Im W; Brooks CL
    J Am Chem Soc; 2004 Dec; 126(49):16038-47. PubMed ID: 15584737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy.
    Skelton NJ; Kördel J; Chazin WJ
    J Mol Biol; 1995 Jun; 249(2):441-62. PubMed ID: 7783203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The solution structure of the Tyr41-->His mutant of the single-stranded DNA binding protein encoded by gene V of the filamentous bacteriophage M13.
    Folkers PJ; Nilges M; Folmer RH; Konings RN; Hilbers CW
    J Mol Biol; 1994 Feb; 236(1):229-46. PubMed ID: 8107108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powder NMR crystallography of thymol.
    Salager E; Stein RS; Pickard CJ; Elena B; Emsley L
    Phys Chem Chem Phys; 2009 Apr; 11(15):2610-21. PubMed ID: 19421517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing quantum-chemical calculation methods for structural investigation of zeolite crystal structures by solid-state NMR spectroscopy.
    Brouwer DH; Moudrakovski IL; Darton RJ; Morris RE
    Magn Reson Chem; 2010 Dec; 48 Suppl 1():S113-21. PubMed ID: 20623826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the three-dimensional fold of a protein from approximate constraints: a simulation study.
    Soman KV; Braun W
    Cell Biochem Biophys; 2001; 34(3):283-304. PubMed ID: 11898858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.
    Engh RA; Dieckmann T; Bode W; Auerswald EA; Turk V; Huber R; Oschkinat H
    J Mol Biol; 1993 Dec; 234(4):1060-9. PubMed ID: 8263913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact area difference (CAD): a robust measure to evaluate accuracy of protein models.
    Abagyan RA; Totrov MM
    J Mol Biol; 1997 May; 268(3):678-85. PubMed ID: 9171291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of an isolated antibody VL domain.
    Constantine KL; Friedrichs MS; Metzler WJ; Wittekind M; Hensley P; Mueller L
    J Mol Biol; 1994 Feb; 236(1):310-27. PubMed ID: 8107112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automatic assignment of NOESY cross peaks and determination of the protein structure of a new world scorpion neurotoxin using NOAH/DIAMOD.
    Xu Y; Jablonsky MJ; Jackson PL; Braun W; Krishna NR
    J Magn Reson; 2001 Jan; 148(1):35-46. PubMed ID: 11133274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of X-ray and NMR structures: is there a systematic difference in residue contacts between X-ray- and NMR-resolved protein structures?
    Garbuzynskiy SO; Melnik BS; Lobanov MY; Finkelstein AV; Galzitskaya OV
    Proteins; 2005 Jul; 60(1):139-47. PubMed ID: 15856480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the nuclear magnetic resonance structure of the DNA-binding domain of the P22 c2 repressor (1 to 76) in solution and comparison with the DNA-binding domain of the 434 repressor.
    Sevilla-Sierra P; Otting G; Wüthrich K
    J Mol Biol; 1994 Jan; 235(3):1003-20. PubMed ID: 8289306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadmium-113 NMR studies on homoleptic complexes containing thioether ligands: the crystal structures of [Cd([12]aneS4)2](ClO4)2, [Cd([18]aneS4N2)](PF6)2 and [Cd([9]aneS3)2](PF6)2.
    Helm ML; Hill LL; Lee JP; Van Derveer DG; Grant GJ
    Dalton Trans; 2006 Aug; (29):3534-43. PubMed ID: 16855755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.